Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993022priorityCriticalpatent/ECSP993022A/es
Publication of ECSP993022ApublicationCriticalpatent/ECSP993022A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Las 5-aril-2,4 -tiazolidindionas son potentes agonistas de PPAR y, por lo tanto, son útiles en el tratamiento, control o prevención de la diabetes, hiperglicemia, hiperlipidemia (incluyendo hipercolesterolemia e hipertrigliceridemia), arterosclerosis, obesidad, restenosis vascular y otras enfermedades, desórdenes y condiciones mediadas por PARR(( (y/o (
ECSP9930221999-06-171999-06-17Derivados de ariltiazolidindiona
ECSP993022A
(es)